| Assessment instruments | Base-line (t0) | 6 weeks (t1) | 3 months follow-up (t2) | 6 months follow-up (t3) |
---|---|---|---|---|---|
1 | Socio-demographics (age, gender, sexual orientation, educational attainment, migration background, financial situation) | X | Â | Â | Â |
2 | Cannabis Use Disorders Identification Test (CUDIT-R) | X | X | X | X |
3 | Cannabis use | Â | Â | Â | Â |
3a | Consumption Patterns (Years of Use, 30-day point prevalence of cannabis and CBD abstinence, Type of Consumption) | X | X | X | X |
3b | Defining the personal standard joint | X | Â | Â | Â |
3c | TLFB (Cannabis use frequency and amount for the last 7Â days in standard joint units) | X | X | X | X |
4 | Severity of Dependence Scale (SDS) | X | X | X | X |
5 | Short version of the Alcohol Use Disorders Identification Test (AUDIT-C) | X | Â | X | X |
6 | National Institute on Drug Abuse Screening (NIDA ASSIST) | X | Â | X | X |
7 | Drug Abuse Screening Test (DAST-10) | X | Â | Â | Â |
8 | Perceived Stress Scale (PSS-10) | X | X | X | X |
9 | Patient Health Questionnaire for Depression (PHQ-9) | X | Â | X | X |
10 | Generalized Anxiety Disorder Screener (GAD-7) | X | Â | X | X |
11 | Adult ADHD Self-Report Scale (ASRS-V1.1) | X | Â | Â | Â |
12 | Mindfulness Attention Awareness Scale (MAAS) | X | X | X | X |
13 | Comprehensive Inventory of Mindfulness Experiences (CHIME) | X | Â | Â | Â |
14 | Previous experience in meditation (no official instrument) | X | Â | Â | Â |
15 | Client Satisfaction Questionnaire for Internet Interventions (CSQ-I) | Â | Xa | Â | Â |
16 | Negative effects, according to Rozental et al. (2015) | Â | X | Â | Â |
17 | Use of any services besides CANreduce | Â | Â | X | X |
18 | Adherence and Retentionb | Â | X | Â | Â |